Literature DB >> 9750920

Dose standardization of botulinum toxin.

P Y Van den Bergh1, D F Lison.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9750920

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


× No keyword cloud information.
  5 in total

Review 1.  Pharmacological differences and clinical implications of various botulinum toxin preparations: a critical appraisal.

Authors:  A Ferrari; M Manca; V Tugnoli; L Alberto
Journal:  Funct Neurol       Date:  2018 Jan/Mar

2.  Retrospective evaluation of the dose equivalence of Botox(®) and Dysport (®) in the management of blepharospasm and hemifacial spasm: a novel paradigm for a never ending story.

Authors:  Anna Rita Bentivoglio; Tàmara Ialongo; Francesco Bove; Francesca De Nigris; Alfonso Fasano
Journal:  Neurol Sci       Date:  2011-06-28       Impact factor: 3.307

Review 3.  Botulinum toxin for the management of bladder dysfunction.

Authors:  Brigitte Schurch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 4.  Focal dystonia: the role of botulinum toxin.

Authors:  R Tintner; J Jankovic
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

Review 5.  Conversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical Practice.

Authors:  Francesco Scaglione
Journal:  Toxins (Basel)       Date:  2016-03-04       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.